Your browser doesn't support javascript.
loading
Attention-Deficit/Hyperactivity Disorder Medication Use in Adolescents: The Patient's Perspective.
Kosse, Richelle C; Bouvy, Marcel L; Philbert, Daphne; de Vries, Tjalling W; Koster, Ellen S.
Afiliación
  • Kosse RC; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Utrecht, The Netherlands.
  • Bouvy ML; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Utrecht, The Netherlands.
  • Philbert D; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Utrecht, The Netherlands.
  • de Vries TW; Department of Pediatrics, Medical Centre Leeuwarden (MCL), Leeuwarden, The Netherlands.
  • Koster ES; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Utrecht, The Netherlands. Electronic address: E.Koster@uu.nl.
J Adolesc Health ; 61(5): 619-625, 2017 Nov.
Article en En | MEDLINE | ID: mdl-28899641
ABSTRACT

PURPOSE:

The purpose of the study was to gain more insight into the attitudes of adolescents using medication for attention-deficit/hyperactivity disorder (ADHD).

METHODS:

A cross-sectional study among adolescents (aged 12-18 years) who filled at least two prescriptions for ADHD medication in the preceding year was conducted. Adolescents were invited to fill in an online questionnaire containing questions on sociodemographics, health status, illness perceptions, medication adherence, and medication beliefs.

RESULTS:

We invited 1,200 adolescents of whom 181 adolescents (122 males, mean age 14.2 ± 1.7 years) completed the online questionnaire. They mostly used methylphenidate (n = 167; 92%) as a pharmacological treatment for ADHD. Half of the study population (n = 93; 51%) experienced side effects, such as decreased appetite and sleep problems. Most participants (n = 150; 83%) had an indifferent attitude (perceived low necessity and low concerns) toward their ADHD medication. More than half of the study population (n = 111; 61%) reported to be nonadherent based on the Medication Adherence Report Scale. The highest score of the Brief Illness Perception Questionnaire was on "treatment control," suggesting that adolescents do think their medication is effective, despite their indifferent drug attitude.

CONCLUSIONS:

Most adolescents using ADHD medication had an indifferent attitude toward their medication and reported low adherence rates. These findings should be taken into account when treating adolescents with ADHD; regular counseling and monitoring of the pharmacological treatment might be useful to optimize treatment.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastorno por Déficit de Atención con Hiperactividad / Cumplimiento de la Medicación / Estimulantes del Sistema Nervioso Central / Metilfenidato Tipo de estudio: Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Límite: Adolescent / Female / Humans / Male Idioma: En Revista: J Adolesc Health Asunto de la revista: PEDIATRIA Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastorno por Déficit de Atención con Hiperactividad / Cumplimiento de la Medicación / Estimulantes del Sistema Nervioso Central / Metilfenidato Tipo de estudio: Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Límite: Adolescent / Female / Humans / Male Idioma: En Revista: J Adolesc Health Asunto de la revista: PEDIATRIA Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos